nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2B—Sorafenib—liver cancer	0.552	0.606	CbGbCtD
Oxymetazoline—HTR2C—Sorafenib—liver cancer	0.359	0.394	CbGbCtD
Oxymetazoline—HTR2C—Signaling by GPCR—PIK3CA—liver cancer	1.47e-05	0.000166	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—APC—liver cancer	1.47e-05	0.000165	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CG—liver cancer	1.47e-05	0.000165	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—JUN—liver cancer	1.47e-05	0.000165	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VEGFA—liver cancer	1.47e-05	0.000165	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RAF1—liver cancer	1.46e-05	0.000164	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CTNNB1—liver cancer	1.46e-05	0.000164	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—STAT3—liver cancer	1.46e-05	0.000164	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—PIK3CA—liver cancer	1.43e-05	0.000161	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MMP9—liver cancer	1.43e-05	0.000161	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MTOR—liver cancer	1.43e-05	0.00016	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3CB—liver cancer	1.43e-05	0.00016	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CDKN1A—liver cancer	1.43e-05	0.00016	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CD—liver cancer	1.42e-05	0.00016	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RAF1—liver cancer	1.42e-05	0.00016	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—HRAS—liver cancer	1.42e-05	0.000159	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKT1—liver cancer	1.41e-05	0.000159	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	1.41e-05	0.000158	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—PIK3CA—liver cancer	1.41e-05	0.000158	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SERPINE1—liver cancer	1.41e-05	0.000158	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RAF1—liver cancer	1.4e-05	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CDKN1B—liver cancer	1.39e-05	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—KRAS—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MAPK8—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3CB—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MTOR—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AKT1—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—BRAF—liver cancer	1.38e-05	0.000155	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MYC—liver cancer	1.38e-05	0.000155	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VEGFA—liver cancer	1.38e-05	0.000155	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AKT1—liver cancer	1.38e-05	0.000155	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	1.38e-05	0.000155	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TGFB1—liver cancer	1.38e-05	0.000155	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	1.38e-05	0.000155	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—STAT3—liver cancer	1.37e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CASP3—liver cancer	1.37e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MTOR—liver cancer	1.37e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	1.37e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL2—liver cancer	1.36e-05	0.000153	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—KRAS—liver cancer	1.36e-05	0.000153	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HRAS—liver cancer	1.36e-05	0.000153	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL6—liver cancer	1.36e-05	0.000153	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MYC—liver cancer	1.35e-05	0.000152	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TGFB1—liver cancer	1.35e-05	0.000152	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CB—liver cancer	1.35e-05	0.000152	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CDKN1B—liver cancer	1.34e-05	0.000151	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCND1—liver cancer	1.33e-05	0.00015	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—JUN—liver cancer	1.33e-05	0.000149	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HRAS—liver cancer	1.33e-05	0.000149	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKT1—liver cancer	1.32e-05	0.000149	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	1.32e-05	0.000148	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CASP3—liver cancer	1.31e-05	0.000148	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL2—liver cancer	1.31e-05	0.000147	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HRAS—liver cancer	1.3e-05	0.000147	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL6—liver cancer	1.3e-05	0.000147	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	1.3e-05	0.000146	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	1.29e-05	0.000145	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MMP9—liver cancer	1.29e-05	0.000145	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	1.29e-05	0.000145	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	1.29e-05	0.000145	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—liver cancer	1.28e-05	0.000144	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	1.28e-05	0.000144	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	1.28e-05	0.000144	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	1.28e-05	0.000144	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—PIK3CA—liver cancer	1.28e-05	0.000144	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCND1—liver cancer	1.28e-05	0.000144	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CASP3—liver cancer	1.28e-05	0.000144	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—KRAS—liver cancer	1.28e-05	0.000143	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—JUN—liver cancer	1.28e-05	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL2—liver cancer	1.27e-05	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—STAT3—liver cancer	1.27e-05	0.000143	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MYC—liver cancer	1.27e-05	0.000143	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RAF1—liver cancer	1.27e-05	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL6—liver cancer	1.27e-05	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	1.27e-05	0.000143	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TGFB1—liver cancer	1.27e-05	0.000142	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—KRAS—liver cancer	1.27e-05	0.000142	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CTNNB1—liver cancer	1.27e-05	0.000142	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CASP3—liver cancer	1.26e-05	0.000141	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MAPK8—liver cancer	1.26e-05	0.000141	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL2—liver cancer	1.25e-05	0.000141	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKT1—liver cancer	1.25e-05	0.000141	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	1.25e-05	0.000141	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—KRAS—liver cancer	1.25e-05	0.00014	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL6—liver cancer	1.25e-05	0.00014	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RAF1—liver cancer	1.24e-05	0.00014	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCND1—liver cancer	1.24e-05	0.00014	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MMP9—liver cancer	1.24e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—JUN—liver cancer	1.24e-05	0.000139	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CB—liver cancer	1.24e-05	0.000139	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MTOR—liver cancer	1.24e-05	0.000139	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CDKN1A—liver cancer	1.24e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	1.23e-05	0.000138	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCND1—liver cancer	1.22e-05	0.000137	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—JUN—liver cancer	1.22e-05	0.000137	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	1.21e-05	0.000136	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MTOR—liver cancer	1.21e-05	0.000136	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	1.21e-05	0.000136	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MMP9—liver cancer	1.21e-05	0.000136	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MAPK8—liver cancer	1.21e-05	0.000136	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKT1—liver cancer	1.2e-05	0.000135	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	1.2e-05	0.000135	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MMP9—liver cancer	1.19e-05	0.000133	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—HRAS—liver cancer	1.18e-05	0.000133	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	1.18e-05	0.000133	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MYC—liver cancer	1.18e-05	0.000133	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TGFB1—liver cancer	1.18e-05	0.000133	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—KRAS—liver cancer	1.17e-05	0.000132	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MAPK8—liver cancer	1.17e-05	0.000132	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PIK3CA—liver cancer	1.17e-05	0.000132	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKT1—liver cancer	1.17e-05	0.000132	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	1.16e-05	0.000131	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CDKN1B—liver cancer	1.16e-05	0.000131	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—liver cancer	1.16e-05	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HRAS—liver cancer	1.16e-05	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MAPK8—liver cancer	1.15e-05	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RAF1—liver cancer	1.15e-05	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKT1—liver cancer	1.15e-05	0.000129	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKT1—liver cancer	1.15e-05	0.000129	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—STAT3—liver cancer	1.15e-05	0.000129	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PIK3CA—liver cancer	1.15e-05	0.000129	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CASP3—liver cancer	1.14e-05	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	1.14e-05	0.000128	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL2—liver cancer	1.14e-05	0.000128	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—liver cancer	1.13e-05	0.000127	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL6—liver cancer	1.13e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	1.13e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MTOR—liver cancer	1.13e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	1.13e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CASP3—liver cancer	1.12e-05	0.000125	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL2—liver cancer	1.11e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—liver cancer	1.11e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—liver cancer	1.11e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCND1—liver cancer	1.11e-05	0.000125	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL6—liver cancer	1.11e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—JUN—liver cancer	1.11e-05	0.000124	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—STAT3—liver cancer	1.1e-05	0.000124	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CTNNB1—liver cancer	1.1e-05	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—KRAS—liver cancer	1.09e-05	0.000123	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCND1—liver cancer	1.09e-05	0.000122	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HRAS—liver cancer	1.08e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—JUN—liver cancer	1.08e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—liver cancer	1.08e-05	0.000122	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PIK3CA—liver cancer	1.08e-05	0.000121	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MMP9—liver cancer	1.08e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HRAS—liver cancer	1.08e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	1.08e-05	0.000121	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CDKN1A—liver cancer	1.07e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—STAT3—liver cancer	1.07e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MYC—liver cancer	1.07e-05	0.00012	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—liver cancer	1.07e-05	0.00012	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TGFB1—liver cancer	1.06e-05	0.00012	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HRAS—liver cancer	1.06e-05	0.000119	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	1.06e-05	0.000119	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—STAT3—liver cancer	1.06e-05	0.000119	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MMP9—liver cancer	1.05e-05	0.000119	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	1.05e-05	0.000118	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MAPK8—liver cancer	1.05e-05	0.000118	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	1.05e-05	0.000118	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKT1—liver cancer	1.04e-05	0.000117	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—liver cancer	1.04e-05	0.000117	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL6—liver cancer	1.04e-05	0.000117	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CASP3—liver cancer	1.04e-05	0.000117	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL2—liver cancer	1.04e-05	0.000116	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL6—liver cancer	1.03e-05	0.000116	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MAPK8—liver cancer	1.03e-05	0.000115	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MYC—liver cancer	1.02e-05	0.000115	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKT1—liver cancer	1.02e-05	0.000115	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TGFB1—liver cancer	1.02e-05	0.000115	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL6—liver cancer	1.02e-05	0.000114	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PIK3CA—liver cancer	1.01e-05	0.000114	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCND1—liver cancer	1.01e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—JUN—liver cancer	1.01e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	1e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	1e-05	0.000112	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HRAS—liver cancer	9.98e-06	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MYC—liver cancer	9.97e-06	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TGFB1—liver cancer	9.94e-06	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—KRAS—liver cancer	9.86e-06	0.000111	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MYC—liver cancer	9.81e-06	0.00011	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MMP9—liver cancer	9.8e-06	0.00011	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TGFB1—liver cancer	9.79e-06	0.00011	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	9.77e-06	0.00011	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—liver cancer	9.71e-06	0.000109	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—liver cancer	9.67e-06	0.000109	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKT1—liver cancer	9.58e-06	0.000108	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STAT3—liver cancer	9.58e-06	0.000108	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL6—liver cancer	9.55e-06	0.000107	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MAPK8—liver cancer	9.53e-06	0.000107	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKT1—liver cancer	9.51e-06	0.000107	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—liver cancer	9.47e-06	0.000106	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—KRAS—liver cancer	9.47e-06	0.000106	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STAT3—liver cancer	9.38e-06	0.000105	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKT1—liver cancer	9.38e-06	0.000105	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HRAS—liver cancer	9.28e-06	0.000104	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—KRAS—liver cancer	9.21e-06	0.000104	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—KRAS—liver cancer	9.07e-06	0.000102	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	9.06e-06	0.000102	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MYC—liver cancer	8.9e-06	0.0001	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6—liver cancer	8.89e-06	9.99e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TGFB1—liver cancer	8.88e-06	9.98e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKT1—liver cancer	8.81e-06	9.9e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—liver cancer	8.8e-06	9.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—liver cancer	8.76e-06	9.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MYC—liver cancer	8.71e-06	9.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STAT3—liver cancer	8.71e-06	9.79e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3CA—liver cancer	8.7e-06	9.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TGFB1—liver cancer	8.69e-06	9.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	8.46e-06	9.51e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—liver cancer	8.42e-06	9.46e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HRAS—liver cancer	8.38e-06	9.42e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	8.33e-06	9.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—AKT1—liver cancer	8.27e-06	9.29e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—KRAS—liver cancer	8.22e-06	9.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3CA—liver cancer	8.22e-06	9.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKT1—liver cancer	8.2e-06	9.21e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—liver cancer	8.19e-06	9.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MYC—liver cancer	8.1e-06	9.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TGFB1—liver cancer	8.08e-06	9.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—liver cancer	8.06e-06	9.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—KRAS—liver cancer	8.05e-06	9.05e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HRAS—liver cancer	8.05e-06	9.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6—liver cancer	8.02e-06	9.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HRAS—liver cancer	7.83e-06	8.8e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HRAS—liver cancer	7.71e-06	8.66e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6—liver cancer	7.7e-06	8.66e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3CA—liver cancer	7.56e-06	8.49e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6—liver cancer	7.49e-06	8.42e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—KRAS—liver cancer	7.48e-06	8.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT1—liver cancer	7.4e-06	8.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	7.4e-06	8.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6—liver cancer	7.37e-06	8.29e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—liver cancer	7.31e-06	8.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—liver cancer	7.16e-06	8.04e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT1—liver cancer	7.11e-06	7.99e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HRAS—liver cancer	6.99e-06	7.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT1—liver cancer	6.91e-06	7.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	6.87e-06	7.73e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HRAS—liver cancer	6.84e-06	7.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT1—liver cancer	6.8e-06	7.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AKT1—liver cancer	6.72e-06	7.55e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6—liver cancer	6.69e-06	7.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—liver cancer	6.65e-06	7.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6—liver cancer	6.55e-06	7.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HRAS—liver cancer	6.36e-06	7.15e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT1—liver cancer	6.17e-06	6.94e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6—liver cancer	6.09e-06	6.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT1—liver cancer	6.04e-06	6.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT1—liver cancer	5.62e-06	6.31e-05	CbGpPWpGaD
